World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
99
Citations
42802
World Ranking
1570
National Ranking
881

Medicine

D-Index
102
Citations
44129
World Ranking
7582
National Ranking
3954

Overview

Berton Zbar is affiliated with the National Institutes of Health in the United States. Their research primarily falls within the field of Biochemistry, Genetics and Molecular Biology, with a focus on several subfields including Molecular Biology, Genetics, Pulmonary and Respiratory Medicine, and Cancer Research.

Their work covers a range of main topics such as:

  • Renal cell carcinoma treatment
  • Renal and related cancers
  • Genetic and Kidney Cyst Diseases
  • Cancer Genomics and Diagnostics
  • Genomic variations and chromosomal abnormalities
  • Epigenetics and DNA Methylation

Among recent publications, three notable papers include:

  • "PRDM10 RCC: A Birt-Hogg-Dubé-like Syndrome Associated With Lipoma and Highly Penetrant, Aggressive Renal Tumors Morphologically Resembling Type 2 Papillary Renal Cell Carcinoma," published in 2023 in Urology
  • "Comprehensive characterization of Alu -mediated breakpoints in germline VHL gene deletions and rearrangements in patients from 71 VHL families," published in 2021 in Human Mutation
  • "Cover, Volume 42, Issue 5," published in 2021 in Human Mutation

Frequent coauthors collaborating with Berton Zbar include:

  • Cathy D. Vocke
  • Christopher J. Ricketts
  • Mark W. Ball
  • W. Marston Linehan
  • Laura S. Schmidt

Their research has been published primarily in the venues of Human Mutation and Urology, with multiple publications in these journals reflecting ongoing contributions to genetic and cancer research.

Best Publications

  • Mutations of the VHL tumour suppressor gene in renal carcinoma

    J.R. Gnarra;K. Tory;Y. Weng;L. Schmidt

  • Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma

    J G Herman;F Latif;Y Weng;M I Lerman

  • Germline and Somatic Mutations in the Tyrosine Kinase Domain of the MET Proto-Oncogene in Papillary Renal Carcinomas

    L. Schmidt;F.-M. Duh;F. Chen;T. Kishida

  • The Heidelberg classification of renal cell tumours

    Gyula Kovacs;Mohammed Akhtar;Bruce J. Beckwith;Peter Bugert

  • HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability

    Jennifer S. Isaacs;Yun Jin Jung;David R. Mole;Sunmin Lee

  • Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome.

    Michael L. Nickerson;Michelle B. Warren;Jorge R. Toro;Vera Matrosova

  • Loss of Alleles of Loci on the Short Arm of Chromosome 3 in Renal Cell Carcinoma

    B. Zbar;H. Brauch;C. Talmadge;M. Linehan

  • Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America.

    Jorge R. Toro;Michael L. Nickerson;Ming Hui Wei;Michelle B. Warren

  • Renal Tumors in the Birt-Hogg-Dubé Syndrome

    Christian P. Pavlovich;McClellan M. Walther;Robin A. Eyler;Stephen M. Hewitt

  • The Genetic Basis of Cancer of the Kidney

    W. Marston Linehan;McCLELLAN M. Walther;Berton Zbar

  • Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors

    Michael L. Nickerson;Erich Jaeger;Yangu Shi;Jeffrey A. Durocher

  • von Hippel-Lindau disease: genetic, clinical, and imaging features.

    P L Choyke;G M Glenn;M M Walther;N J Patronas

  • Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype

    Chen F;Kishida T;Yao M;Hustad T

  • Improved detection of germline mutations in the von Hippel‐Lindau disease tumor suppressor gene

    Catherine Stolle;Gladys Glenn;Berton Zbar;Jeffrey S. Humphrey

  • Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan.

    Berton Zbar;Takeshi Kishida;Fan Chen;Laura Schmidt

  • Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.

    T Shuin;K Kondo;S Torigoe;T Kishida

  • Risk of Renal and Colonic Neoplasms and Spontaneous Pneumothorax in the Birt-Hogg-Dubé Syndrome

    Berton Zbar;W. Gregory Alvord;Gladys Glenn;Maria Turner

  • Novel mutations of the MET proto-oncogene in papillary renal carcinomas.

    L. Schmidt;K. Junker;N. Nakaigawa;T. Kinjerski

  • Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling

    Masaya Baba;Seung-Beom Hong;Nirmala Sharma;Michelle B. Warren

  • Immunotherapy of Cancer: Regression of Intradermal Tumors and Prevention of Growth of Lymph Node Metastases After Intralesional Injection of Living Mycobacterium bovis

    Berton Zbar;Irwin D. Bernstein;Gerald L. Bartlett;Michael G. Hanna

Frequent Co-Authors

Michael I. Lerman
Michael I. Lerman National Institutes of Health
Farida Latif
Farida Latif University of Birmingham
Herbert J. Rapp
Herbert J. Rapp National Institutes of Health
Laura S. Schmidt
Laura S. Schmidt National Institutes of Health
W. Marston Linehan
W. Marston Linehan National Institutes of Health
Hiltrud Brauch
Hiltrud Brauch German Cancer Research Center
McClellan M. Walther
McClellan M. Walther National Institutes of Health
Peter L. Choyke
Peter L. Choyke National Institutes of Health
Maria J. Merino
Maria J. Merino National Institutes of Health
Tibor Borsos
Tibor Borsos National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Berton Zbar

Trending Scientists